Sugemalimab trials for Lung cancer

All Sugemalimab trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Sugemalimab for Lung cancer

• A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC
  NCT06617416 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
  NCT06217757 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
  NCT05623267 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Sugemalimab for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.